| Name | Title | Contact Details |
|---|
Applied Cardiac Systems Inc is a Laguna Hills, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Anthelio Healthcare Solutions Inc. is much more than a healthcare IT company. We are a single source provider of world-class technology solutions for the healthcare industry with a 15-year history of excellence. Our innovative services and products make it easier for our customers to do what they do best – deliver outstanding patient care. Our company was built on the foundation that healthcare is our only business, uniquely positioning us as one of the very few companies who focus solely on the needs of our healthcare customers and their patients. We take great pride in maintaining the highest levels of client satisfaction for the hundreds of U.S. hospitals and healthcare providers we serve. We strive to provide a unique customer experience by proactively anticipating our customers' needs and pain points and by delivering fast, flexible and bold solutions. In an ever-evolving healthcare industry, we are at the forefront of delivering cutting-edge, scalable technologies and solutions that respond to the market's needs while maintaining sustainable value to our customers.
Nutracea, Inc. is a Paradise Valley, AZ-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
J D Imaging Svc is a Mundelein, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
StemCells, Inc., a biopharmaceutical company, engages in the research, development, and commercialization of cell-based therapeutics and tools for use in stem cell-based research and drug discovery primarily in the United States. Its lead therapeutic product candidate, HuCNS-SC cells (purified human neural stem cells), is in development as a potential treatment for a range of central nervous system disorders. The company has conducted a Phase I clinical trial in Pelizaeus-Merzbacher disease, a fatal myelination disorder in children. It is also conducting a Phase I/II clinical trial in chronic spinal cord injury; and has initiated a Phase I/II clinical trial in dry age-related macular degeneration, as well as is pursuing preclinical studies in Alzheimer’s disease. In addition, the company markets a rage of proprietary cell culture products, research grade human cells, and antibody reagents under the SC Proven brand. The proprietary cell culture products include iSTEM, GS1-R, GS2-M, RHB-A, RHB-Basal, NDiff227, NDiff N2, and NDiff N27 supplements, as well as HEScGRO and ESGRO Complete; and antibody reagents comprise STEM24, STEM101, STEM121, and STEM123, which can be used for cell detection, isolation, and characterization. Further, StemCells is involved in developing and commercializing applications of its technologies to enable stem cell-based research. The company sells its tools and technologies products to researchers at academic institutions, pharmaceutical and biotechnology companies, and government laboratories. StemCells, Inc. was founded in 1988 and is headquartered in Newark, California.